In an AD animal model, EA at GV20 and GV29 upregulated the expression of triggering receptors expressed on myeloid cells 2 (TREM2) in the hippocampus, ameliorating learning and memory dysfunction and protecting neurons (Li Y. et al., 2020). The gene discussed is TREM2; the disease is Alzheimer disease.